Biograil™ was established in 2019 and is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD™ technology to unlock the potential of transforming markets of injectable pharmaceutical products into convenient oral capsules.
Karsten Lindhardt, CEO & Founder
Nikolaj Skak, CTO & Founder
Kamille Dumong Erichsen, Non-Clinical Project Director
Nils Piwon, Portfolio and Alliance Director
Martin Rex Olsen, Manufacturing Director
Lisbeth Nordly Lauritzen, PA